Medicare

Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024

Retrieved on: 
Tuesday, March 5, 2024

Total revenue for the fourth quarter of 2023 was $10.7 million, an increase of 30% compared to the fourth quarter of 2022.

Key Points: 
  • Total revenue for the fourth quarter of 2023 was $10.7 million, an increase of 30% compared to the fourth quarter of 2022.
  • GAAP gross margin for the fourth quarter of 2023 was 23%, which was slightly higher than the 22% GAAP gross margin reported for the fourth quarter of 2022.
  • Fourth quarter 2023 GAAP operating expense was $27.4 million, compared to $39.3 million in the fourth quarter of 2022.
  • Fourth quarter 2023 non-GAAP operating expense was $27.3 million, compared to $30.6 million in the fourth quarter of 2022.

CMS awards Noridian Medicare DME contract for third time

Retrieved on: 
Tuesday, March 5, 2024

FARGO, N.D., March 05, 2024 (GLOBE NEWSWIRE) -- Noridian Healthcare Solutions, LLC (Noridian) , a leader in developing solutions for federal, state and commercial health care programs, proudly announces the re-award of the Durable Medical Equipment (DME) Medicare Jurisdiction D (JD) contract.

Key Points: 
  • FARGO, N.D., March 05, 2024 (GLOBE NEWSWIRE) -- Noridian Healthcare Solutions, LLC (Noridian) , a leader in developing solutions for federal, state and commercial health care programs, proudly announces the re-award of the Durable Medical Equipment (DME) Medicare Jurisdiction D (JD) contract.
  • The Centers for Medicare & Medicaid Services (CMS) recently re-awarded Noridian the $152.8 million contract, concluding a full-and-open competitive procurement.
  • Territories, Noridian processes more than 13 million fee-for-service (FFS) claims for nearly 25,000 DME suppliers, resulting in $2.6 billion in payments for the JD contract.
  • For nearly two decades, Noridian has diligently served the suppliers and beneficiaries of JD,” said Noridian president and CEO Jon Bogenreif.

Aledade Takes Steps to Support Independent Primary Care Partners in Wake of Change Healthcare CyberAttack

Retrieved on: 
Tuesday, March 5, 2024

BETHESDA, MD, March 05, 2024 (GLOBE NEWSWIRE) -- Aledade , the nation’s largest network of independent primary care, today announced actions it is taking to support its network of primary care practices nationwide facing severe financial strain and other repercussions in the aftermath of the Change Healthcare cyberattack.

Key Points: 
  • BETHESDA, MD, March 05, 2024 (GLOBE NEWSWIRE) -- Aledade , the nation’s largest network of independent primary care, today announced actions it is taking to support its network of primary care practices nationwide facing severe financial strain and other repercussions in the aftermath of the Change Healthcare cyberattack.
  • “We have heard clearly from our practices that they need help to keep providing high quality patient care and their doors open,” said Farzad Mostashari, M.D., co-founder and CEO of Aledade.
  • “This is a financial emergency for a substantial number of independent practices nationwide.
  • We need decisive policy action to inject liquidity into the system until alternative payment workflows are established.

InnovAge Launches First PACE Center in Florida Providing Comprehensive Healthcare Program for Seniors to Promote Independence

Retrieved on: 
Monday, March 4, 2024

TAMPA, Fla., March 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), the industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE) launched a new center in Tampa, its first in the state of Florida.

Key Points: 
  • TAMPA, Fla., March 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), the industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE) launched a new center in Tampa, its first in the state of Florida.
  • “For more than 30 years, InnovAge has been providing critical healthcare programs for seniors across the country, and so, I am honored to celebrate our expansion into the state of Florida,” said Patrick Blair, President and CEO of InnovAge.
  • InnovAge tailors healthcare services to each participant, through customized care plans developed in partnership with seniors, their loved ones, and the company’s healthcare providers, helping to empower seniors and promote independence and well-being.
  • InnovAge centers are embedded in the communities seniors live in and are uniquely positioned to help them holistically.

LifeWallet Announces a Comprehensive Settlement with 28 Affiliated Property and Casualty Insurers, Benefiting LifeWallet’s Medicare Clients Across the U.S.

Retrieved on: 
Monday, March 4, 2024

The settlement creates an environment where Secondary Payers,2 such as health insurance plans and healthcare providers, discover Medicare liens owed to them and recover conditional payments from responsible primary plans, such as property and casualty insurers.

Key Points: 
  • The settlement creates an environment where Secondary Payers,2 such as health insurance plans and healthcare providers, discover Medicare liens owed to them and recover conditional payments from responsible primary plans, such as property and casualty insurers.
  • This will enhance LifeWallet’s ability to discover liens and recover payments owed, more quickly than through litigation.
  • It also enables LifeWallet to pursue a diversified number of entities that failed to pay liens or collected twice for the same bills, both from the insurer and LifeWallet’s assignor clients.
  • Utilizing LifeWallet’s unique payer-based knowledge, artificial intelligence (“AI”) and blockchain-based LifeChain integrations, LifeWallet has developed a comprehensive coordination of benefits clearinghouse.

Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller

Retrieved on: 
Monday, March 4, 2024

NEWTOWN, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Centers for Medicare & Medicaid Services (“CMS”) has assigned Healthcare Common Procedure Coding System (“HCPCS”) Level II codes A4593, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime” to describe the PoNS controller and A4594, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each” to describe the PoNS mouthpiece. The new HCPCS codes will be effective April 1, 2024.

Key Points: 
  • The new HCPCS codes will be effective April 1, 2024.
  • “PoNS Therapy® is life-changing for people who suffer gait impairment due to MS and we’re pleased that CMS understood the benefits of this innovative treatment by establishing HCPCS codes for both the PoNS mouthpiece and controller.
  • This marks a critical reimbursement and access milestone and provides Helius the ability to begin negotiating reimbursement with third-party payers using these unique HCPCS codes.
  • In Canada, PoNS is authorized to treat balance impairment due to MS, stroke and mild-to-moderate traumatic brain injury.

ASRT CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Assertio Holdings, Inc. (ASRT)

Retrieved on: 
Monday, March 4, 2024

The action charges Assertio with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.

Key Points: 
  • The action charges Assertio with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • As a result of Assertio’ s materially misleading statements and omissions to the public, Assertio’ s investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Assertio investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The class action complaint against Assertio, Shapiro v. Assertio Holdings, Inc., et al., Case No.

AMPL ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Amplitude, Inc.

Retrieved on: 
Sunday, March 3, 2024

The action charges Amplitude with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.

Key Points: 
  • The action charges Amplitude with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • Our securities fraud litigators are regularly recognized as leaders in the field as well as the firm itself which is continuously awarded for the successful results we’ve achieved.
  • Kessler Topaz Meltzer & Check, LLP encourages Amplitude investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

MBLY INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on March 18, 2024 in Securities Fraud Class Action Lawsuit Filed against MBLY Holdings Limited

Retrieved on: 
Sunday, March 3, 2024

Kessler Topaz Meltzer & Check, LLP encourages Mobileye investors who have suffered significant losses to contact the firm directly to acquire more information.

Key Points: 
  • Kessler Topaz Meltzer & Check, LLP encourages Mobileye investors who have suffered significant losses to contact the firm directly to acquire more information.
  • A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.
  • Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Palo Alto Networks, Inc. (PANW)

Retrieved on: 
Saturday, March 2, 2024

RANDOR, Pa., March 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Palo Alto Networks, Inc. (“Palo Alto”) ( NASDAQ: PANW ).

Key Points: 
  • RANDOR, Pa., March 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Palo Alto Networks, Inc. (“Palo Alto”) ( NASDAQ: PANW ).
  • The action charges Palo Alto with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • Kessler Topaz Meltzer & Check, LLP encourages Palo Alto investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The class action complaint against Palo Alto, Schlaegel v. Palo Alto Networks, Inc., et al., Case No.